{"id":"W2210409510","doi":"10.1161/jaha.115.002546","title":"Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery","year":2015,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"National Institutes of Health; Regado Biosciences; Medicines Company; Stanford Bio-X; MyoKardia; Gilead Sciences; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Servier; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Odds ratio; Myocardial infarction; Acute coronary syndrome; Perioperative; Cardiology; Placebo; Aspirin; Stroke (engine); Clinical endpoint; Platelet aggregation inhibitor; Anesthesia; Surgery; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001317321,0.0002197285,0.0007997932,0.0002318477,0.0001070481,0.0005480421,0.0002148681,0.0003281535,0.0006657068],"category_scores_gemma":[0.00307328,0.0001271802,0.0007129673,0.0002296803,0.0003161197,0.0002958115,0.0001750367,0.0004599522,0.00008238442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003390704,"about_ca_system_score_gemma":0.0003698653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002950201,"about_ca_topic_score_gemma":0.000572186,"domain_scores_codex":[0.9992993,0.0003866627,0.00007985286,0.00007434076,0.0001178066,0.00004205367],"domain_scores_gemma":[0.998158,0.0008144595,0.0006556757,0.00006223656,0.00008014009,0.0002294287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3547148,0.003135638,0.4566588,0.001890027,0.005726828,0.0004382258,0.0003271828,0.0009390009,0.007441921,0.0003354396,0.001419976,0.1669722],"study_design_scores_gemma":[0.04885881,0.09380631,0.8456391,0.0003265332,0.003133931,0.0008611191,0.0002402978,0.002626173,0.001837659,0.0004149606,0.002205996,0.00004912926],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940499,0.005299564,0.00004909976,0.0001152709,0.00002855969,0.00002956265,0.0000906511,0.00000397792,0.0003334532],"genre_scores_gemma":[0.9984124,0.00112245,0.00008472072,0.00006807884,0.00005886308,0.00002096705,0.0001855001,9.781892e-7,0.00004606599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001317321,"threshold_uncertainty_score":0.00696677,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01067373888236552,"score_gpt":0.2499205182077375,"score_spread":0.239246779325372,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}